Oxytocin 2mg from Adaptog Peptides is a nine-amino-acid neuropeptide widely used in social-behaviour, reproductive, and neurochemistry research. Investigators select Oxytocin for its well-characterised binding profile at the OXTR receptor and its role across central and peripheral signalling systems. Adaptog supplies Oxytocin 2mg as a high-purity reagent suited to studies requiring consistent receptor engagement, predictable kinetics, and reliable batch-to-batch performance.
Oxytocin remains one of the most extensively studied peptides in neuroendocrinology, with relevance spanning social cognition, parturition, lactation, and stress-response modelling. Adaptog Peptides supplies Oxytocin 2mg for laboratories that need a stable, well-defined reagent for receptor-binding studies and behavioural neuroscience protocols.
Researchers often buy Oxytocin 2mg from Adaptog Peptides for projects such as:
Examining OXTR receptor activation and downstream signalling
Investigating peripheral effects on smooth muscle in isolated tissue models
Studying interactions between oxytocinergic and vasopressinergic systems
Modelling social-bonding and stress-buffering pathways in controlled paradigms
Because Oxytocin acts on both central and peripheral targets, it supports diverse research programmes from molecular pharmacology through to systems neuroscience. Adaptog Peptides delivers Oxytocin 2mg as a research-grade compound intended only for qualified laboratory environments. It is not for clinical, diagnostic, or therapeutic use.
For research use only. Not for human consumption.
Oxytocin remains one of the most extensively studied peptides in neuroendocrinology, with relevance spanning social cognition, parturition, lactation, and stress-response modelling. Adaptog Peptides supplies Oxytocin 2mg for laboratories that need a stable, well-defined reagent for receptor-binding studies and behavioural neuroscience protocols.
Researchers often buy Oxytocin 2mg from Adaptog Peptides for projects such as:
Examining OXTR receptor activation and downstream signalling
Investigating peripheral effects on smooth muscle in isolated tissue models
Studying interactions between oxytocinergic and vasopressinergic systems
Modelling social-bonding and stress-buffering pathways in controlled paradigms
Because Oxytocin acts on both central and peripheral targets, it supports diverse research programmes from molecular pharmacology through to systems neuroscience. Adaptog Peptides delivers Oxytocin 2mg as a research-grade compound intended only for qualified laboratory environments. It is not for clinical, diagnostic, or therapeutic use.
For research use only. Not for human consumption.
| Type | Synthetic compound |
|---|---|
| Category | Research Compound |
| Purity | ≥99% |
| Form | Lyophilized powder |
-20°C · 24+ months
2–8°C · ~30 days
Third-party tested for purity and quality.
| Variant | GLP3-RT 10mg |
|---|---|
| Lot # | REF0001 |
| Labeled | 20mg |
| Actual | 22.61mg |
| Tested | APR 15, 2026 |
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Triple–Hormone-Receptor Agonist GLP-3 (RT) for Obesity — A Phase 2 Trial
2023
DOI: 10.1056/NEJMoa2301972
· Jastreboff AM, et al.
Not a researcher? Exit
